Microbial-Based Cancer Immunotherapy

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
Lillian Sun, Pauline Funchain, Jung Min Song, Patricia Rayman, Charles Tannenbaum, Jennifer Ko, Michael Mcnamara, C. Marcela Diaz-Montero, Brian Gastman

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 36; DOI: 10.1186/s40425-018-0337-7
White paper on microbial anti-cancer therapy and prevention
Neil S. Forbes, Robert S. Coffin, Liang Deng, Laura Evgin, Steve Fiering, Matthew Giacalone, Claudia Gravekamp, James L. Gulley, Hal Gunn, Robert M. Hoffman, Balveen Kaur, Ke Liu, Herbert Kim Lyerly, Ariel E. Marciscano, Eddie Moradian, Sheryl Ruppel, Daniel A. Saltzman, Peter J. Tattersall, Steve Thorne, Richard G. Vile, Halle Huihong Zhang, Shibin Zhou, Grant McFadden

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 78; DOI: 10.1186/s40425-018-0381-3
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
Janet Lei, Egon J. Jacobus, William K. Taverner, Kerry D. Fisher, Silvio Hemmi, Katy West, Lorna Slater, Fred Lilley, Alice Brown, Brian Champion, Margaret R. Duffy, Len W. Seymour

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 55; DOI: 10.1186/s40425-018-0350-x
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference
Donald Bastin, Amelia S. Aitken, Adrian Pelin, Larissa A. Pikor, Mathieu J. F. Crupi, Michael S. Huh, Marie-Claude Bourgeois-Daigneault, John C. Bell, Carolina S. Ilkow

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 62; DOI: 10.1186/s40425-018-0366-2

Log in using your username and password

Main menu

Log in using your username and password

You are here

Microbial-Based Cancer Immunotherapy